Related Experiment Video
Updated: Aug 18, 2026

A Modified Technique for Inducing Polycystic Ovary Syndrome in Mice
Published on: July 5, 2024
Polycystic ovary syndrome--a management update
1University of New South Wales. mfcostello@unsw.edu.au
Background:
Polycystic ovary syndrome (PCOS) is the most common endocrinopathy in women and is associated with both reproductive and metabolic disorders.
Objective:
This article discusses the health risks, clinical assessment and investigations consistent with the new internationally agreed definition of PCOS, available treatments, and the long-term monitoring of women with PCOS.
Discussion:
Women with PCOS have an increased risk of endometrial carcinoma, type 2 diabetes mellitus, and possibly cardiovascular disease. Polycystic ovary syndrome is a diagnosis of exclusion of other causes of hyperandrogenism. Screening for diabetes is important. Treatment is directed at the presenting symptom as the primary cause is unknown. Long-term medical treatment may include the oral contraceptive pill or metformin. Long-term surveillance is recommended for the early detection and treatment of potential metabolic complications.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Nephrotic Syndrome II : Assessment and Medical Management
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Cushing Syndrome II: Pathophysiology

